BioPharmSignal logoBioPharmSignal

Biotech News

Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Artivion (AORT)ArtivionConference / presentation

ATLANTA, March 3, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate virtually at the upcoming Oppenheimer 36 th Annual Healthcare MedTech & Services Conference.

Open original release

Related news

RXSTRxSight2026-04-02 20:10 EST

RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference

HYPRHyperfine2026-05-06 20:05 EST

Hyperfine, Inc. to Participate in Upcoming 2026 Jefferies Global Healthcare Conference

IARTIntegra LifeSciences2026-06-02 11:30 EST

Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference

CVRXCVRx2026-05-27 20:30 EST

CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

PLSEPulse Biosciences2026-05-27 20:05 EST

Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

ANGOAngioDynamics2026-05-27 12:30 EST

AngioDynamics to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

ATRCAtriCure2026-05-27 12:00 EST

AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference

DCTHDelcath Systems2026-05-12 12:00 EST

Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference

PLSEPulse Biosciences2026-05-08 11:00 EST

Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference

RXSTRxSight2026-04-29 20:10 EST

RxSight, Inc. to Present at the Bank of America Healthcare Conference

View all latest news

Artivion

Artivion is a medical device company focused on cardiovascular surgery, aortic repair, and preservation technologies. Its products are used in complex cardiac and vascular procedures.

Recent company news

AORTArtivion2026-05-18 11:00 EST

Artivion Completes Acquisition of Endospan Ltd.

AORTArtivion2026-05-07 20:05 EST

Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan

AORTArtivion2026-04-23 20:15 EST

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results

AORTArtivion2026-04-07 11:00 EST

Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System

AORTArtivion2026-03-03 21:10 EST

Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Stock data

Close
26.10 USD
Market cap
991.26M USD
Exchange
NYSE
Sector
MedTech
Location
United States